Viewing Study NCT03543358


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2025-12-25 @ 10:32 PM
Study NCT ID: NCT03543358
Status: COMPLETED
Last Update Posted: 2021-01-05
First Post: 2018-05-21
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Long-Term Study of Rovalpituzumab Tesirine
Sponsor: AbbVie
Organization: